Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

An expert underscores the importance of early expectation setting around chronicity, symptom variability, and realistic treatment goals for children with functional constipation or IBS-C.

Successful long-term management of pediatric functional constipation and IBS-C requires more than selecting a specific therapy; it depends heavily on how clinicians frame the conditions and set expectations with families. Julie Khlevner, MD, recommends presenting these disorders early as chronic, often relapsing conditions with fluctuating symptom intensity rather than problems that will respond to a rapid or linear cure. She finds that normalizing symptom variability from the outset can help reduce anxiety when symptoms recur, mitigate repeated urgent reassessments, and decrease reliance on unnecessary investigations.

In functional constipation, Khlevner observes that many families expect laxatives to “fix” the problem within weeks, whereas underlying drivers—such as withholding behaviors, altered anorectal sensation, rectal dilation, and dysfunctional toileting patterns—frequently require months to improve. She emphasizes that maintenance therapy often must continue even after stool frequency normalizes, with careful tapering only when appropriate. Without explicit counseling, families may stop treatments prematurely or use medications inconsistently, leading to relapse and a loss of confidence in the care plan.

For IBS-C, Khlevner highlights that outcomes are typically judged by reductions in symptom burden and improvements in daily functioning, not complete symptom resolution. She deliberately distinguishes symptom improvement, functional improvement, and full symptom eradication, and she aligns therapeutic goals through shared decision-making. She also notes that a subset of children will continue to experience symptoms into adulthood, underscoring the importance of planned transition-of-care strategies. Clear, early communication about chronicity, timelines, and realistic targets can preserve adherence and sustain therapeutic alliances over the course of a child’s development.